Brief: Achieve Life Sciences entered into exclusive supply agreement with Sopharma AD
26/10/2017 10:31
Oct 26 (Reuters) - Sopharma Ad 3JR.BB
* Achieve Life Sciences - co entered into exclusive supply
agreement with Sopharma AD for manufacture of Cytisine API and
finished tablets
* Achieve Life Sciences Inc - exclusive license agreement
provides supply of Cytisine to co for up to 20 years
* Achieve Life Sciences Inc - sopharma agrees to produce
CGMP-grade Cytisine for achieve's use in development and
commercialization of Cytisine
Source text for Eikon: ID:nCNWZBpxDa
Further company coverage: 3JR.BB
((Bangalore.newsroom@thomsonreuters.com;;))